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E-mail address: tanaka@med.uoeh-u.ac.jp (Y. TanaAlthough increased vascular permeability is known to be a major characteristic of diabetic vasculop-
athy, the precise mechanisms and relevance of advanced glycation end products (AGE) to hyperper-
meability of vessels remains unclear. Here, we studied changes in cytoskeletal conﬁguration and the
signaling mechanism induced by AGE in human endothelial cells. AGE-BSA stimulation induced Rho
activation, intercellular gap formation, prominent actin stress ﬁber and cell contraction without
changing VE-cadherin, and subsequently transendothelial diffusion of FITC-labeled dextran. These
processes induced by AGE-BSA were inhibited by either Rho-kinase inhibitor Y27632 or anti-RAGE
antibody. We also showed that RhoA and RAGE spontaneously formed a complex. These ﬁndings
suggest that activation of RAGE/Rho is involved in AGE-BSA-induced hyperpermeability through
gap formation and actin reorganization in diabetes.
Structured summary:
MINT-7301170: Rhotekin (uniprotkb:Q9BST9) physically interacts (MI:0915) with RhoA (uni-
protkb:P61586) by pull down (MI:0096)
MINT-7301204, MINT-7301186: RhoA (uniprotkb:P61586) physically interacts (MI:0915) with RAGE (uni-
protkb:Q15109) by anti bait coimmunoprecipitation (MI:0006)
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Diabetic mellitus is a chronic progressive disease associated
with serious complication including various vasculopathies. In-
creased capillary permeability occurs in the early stages of diabetes
before the onset of structural angiopathy and is known to be a ma-
jor characteristic of diabetic vasculopathy [1–4]. However, little is
known about the intracellular signals that propagate these endo-
thelial structural changes and lead to hyperpermeability during
pathological processes of diabetes.
Endothelial structural changes, weak or loss of adherence junc-
tion, cell contraction, and focal adhesion redistribution are consid-
ered involved in hyperpermeability induced by various insults
such as inﬂammatory stimuli [5]. Previous studies also reported
the disorganization of tight junction structures in diabetic retina
and cerebral microvessels [6], suggesting that these abnormalities
could explain diabetic hyperpermeability. Another studies indi-
cated that high glucose induces actin stress ﬁber formation in
endothelial cells [7] and that microvascular leakage in the retinal
microvasculature is enhanced in STZ-induced diabetic rats withchemical Societies. Published by E
ka).high levels of F-actin stress ﬁbers [8], suggesting a relation be-
tween hyperglycemia and cytoskeletal contraction, which leads
to hyperpermeability.
Accumulated evidence indicates that advanced glycation end
products (AGEs) increase at an accelerated rate in diabetes and in
parallel with the severity of diabetic complications [9]. AGEs acti-
vate RAGEs, a major receptor for AGEs, modulate various cell func-
tions and play a role in vasculopathies through multiple
intracellular signal transduction pathways, including p21ras, MAP
kinases, PI3 kinase and many [4,10]. However, the relationship
AGE with the receptor and the following signaling pathways was
unclear. In this study to clarify the signaling mechanism that lead
to papillary hyperpermeability in diabetes, we investigated changes
in cytoskeletal conﬁguration induced by AGE and the role of the
RAGE/Rho signaling pathway in AGE-mediated microvascular
hyperpermeability using human vascular endothelial cells in vitro.2. Materials and methods
2.1. Antibodies and materials
Mouse monoclonal antibodies (mAb) to human VE-cadherin and
human RAGEwere purchased fromR&D Systems (Minneapolis,MN).lsevier B.V. All rights reserved.
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(Santa Cruz, CA), mouse mAb to human b-actin was from Sigma
(St. Louis, MO), and horseradish peroxidase-conjugated horse anti-
mouse secondary antibody was from Amersham Biosciences
(Arlington Heights, IL). Rhodamine–phalloidin and Alexa Fluor
488-conjugated goat anti-mouse secondary antibody were pur-
chased from Invitrogen (Carlsbad, CA). AGE-bovine serum albumin
(BSA) was purchased from BioVision (Mountain View, CA), BSA
was from Sigma. Rho-kinase inhibitor Y27632 was obtained from
Biomol (Plymouth Meeting, PA).
2.2. Cell culture
Human umbilical vein endothelial cells (HUVECs) were ob-
tained from Cambrex (Walkersville, MD) and cultured in EGM-2
(Lonza) complete medium containing 2% (v/v) fetal bovine serum
(FBS), multiple recombinant human growth factors including vas-
cular endothelial growth factor (VEGF), ﬁbroblast growth factor
(FGF), insulin growth factor-1 (IGF1), and epidermal growth factor,
as well as hydrocortisone, heparin, and ascorbic acid. Experiments
were performed using cells up to passage 3. Where appropriate,
cells were starved in serum-free basal EBM-2 (Lonza) medium
prior to treatment.
2.3. Endothelial monolayer permeability assay
HUVEC were plated in 24-well Transwell units (with polycar-
bonate membrane, 8-lm pores; Nunc) pre-coated with ﬁbronectin
(2.5 lg/well) and cultured to conﬂuence in EGM-2. At the start of
the experiment, the culture medium in the lower and upper com-
partments was replaced with EBM-2 containing AGE-BSA or con-
trol BSA. After incubation, FITC-labeled dextran (initial
concentration 400 lg/ml) was added to the upper compartment.
After 1 h of additional incubation at 37 C, the medium in the lower
compartments was collected and analyzed in a ﬂuorescence detec-
tor using 485 nm and 538 nm as the excitation and emission wave-
lengths, respectively.
2.4. Fluorescent staining of F-actin and VE-cadherin
HUVECs were plated in glass-bottom 35-mm dishes pre-coated
with ﬁbronectin (2.5 lg/well) and cultured to conﬂuence in EGM-
2. At the start of the experiment, the culture medium was replaced
with EBM-2 containing AGE-BSA or control BSA. After incubation,
the cells were ﬁxed in 3.7% formaldehyde solution for 3 min and
permeabilized with 0.1% Triton X-100 for 3 min. They were then
incubated with rhodamine–phalloidin for 20 min in room temper-
ature to stain F-actin. For staining VE-cadherin, cells were ﬁxed in
3.7% formaldehyde solution for 10 min then incubated with mAbs
against VE-cadherin at room temperature for 1 h, followed by
Alexa Fluor 488-conjugated secondary antibody at room tempera-
ture in the dark for 1 h. Fluorescence was detected with a Zeiss Axi-
ophot microscope.
2.5. Western blotting
HUVECs were cultured in cell culture dishes to conﬂuence. Cells
were starved in serum-free medium for 1 h and then exposed to
BSA or AGE-BSA (50 lg/ml) for different times as indicated. Cell ex-
tracts were prepared with a lysis buffer as previously described
[11]. Protein concentrationwas determinedwith Bradford reaction.
2.6. Rho activation assay
Rho activation was determined by a pull-down assay using GST-
Rhotekin-Rho-binding domain (GST-RBD). HUVEC were cultured incell culture dishes to conﬂuence. Cells were starved in serum-free
medium for 6 h and then exposed to AGE-BSA (50 lg/ml) or BSA
(50 lg/ml) for different times as indicated, quickly washed with
ice-cold Tris-buffered saline, and lysed in 500 ll of lysis buffer. Cell
lysates were immediately centrifuged at 8000 rpm at 4 C for 5 min
and equal volumes of lysates were incubated with 30 lg GST-RBD
beads for 1 h at 4 C. The beads were washed with wash buffer, and
bound Rho was eluted by boiling each sample in Laemmli sample
buffer. Eluted samples from the beads and total cell lysate were
then electrophoresed on 15% SDS–polyacrylamide gel electropho-
resis gels, transferred to nitrocellulose, blocked with 5% non-fat
milk, and analyzed by Western blotting using a polyclonal anti-
Rho antibody.
2.7. Immunoprecipitation
Immunoprecipitations were carried out utilizing RhoA or RAGE
antibodies. HUVEC were cultured in cell dishes to conﬂuence. Cells
were starved in serum-free medium for 6 h and then exposed to
AGE-BSA (50 lg/ml) or serum-free medium only for 10 min,
quickly washed with ice-cold Tris-buffered saline, and lysed in
500 ll of lysis buffer. Cell lysates were immediately centrifuged
at 8000 rpm at 4 C for 5 min. The supernatants were incubated
end-over-end for 60 min at 4 C with the mixture with Protein G
sepharose beads, which were incubated end-over-end for 30 min
at 4 C with anti-RAGE antibody (5 lg/ml) or anti-RhoA antibody
(5 lg/ml). The beads were washed three times with PBS-T, then
treated with elution buffer (2.5% acetic acid), and the eluted immu-
noprecipitated samples were resuspended in Laemmli buffer and
heated at 100 C for 3 min, and analyzed by SDS–PAGE, transferred
to nitrocellulose, blocked with 5% non-fat milk, and analyzed by
Western blotting using a monoclonal anti-Rho antibody or anti-
RAGE antibody.
2.8. Statistical analysis
All data were obtained from at least ﬁve independent experi-
ments performed in triplicate. Results were expressed as
means ± S.D. Analyses of differences were carried out by ANOVA
followed by posthoc Student Newman Keuls test. A P value < 0.05
was considered statistically signiﬁcant.3. Results
3.1. AGE-BSA increases endothelial permeability
First, we investigated the effect of AGEs on permeability of hu-
man endothelial cells by observing diffusion of dextran in HUVEC.
AGE-BSA increased transendothelial diffusion of FITC-labeled dex-
tran in a time-dependent and a dose-dependent manner, whereas
unmodiﬁed BSA had no effect on the permeability (Fig. 1A and B).
These ﬁndings suggest AGE-BSA have a potential to induce endo-
thelial permeability and disturb the physiological barrier of capil-
lary endothelium.
3.2. AGE-BSA causes intercellular gap formation and reorganization of
actin cytoskeleton
To test whether AGEs-induced changes in permeability are due
to morphological changes in the endothelial cells, we stained actin
and VE-cadherin in endothelial cells treated with or without AGE-
BSA. While control cells and cells treated with BSA showed cobble-
stone morphology without intercellular gap, endothelial cells trea-
ted with AGE-BSA showed intercellular gap formation (Fig. 2A-a).
Next, we focused on the changes in the cytoskeleton. Although
Fig. 1. AGE-BSA perturbed the endothelial barrier of cultured HUVEC monolayers.
(A) HUVEC on Transwell inserts were incubated with 50 lg/ml AGE-BSA for the
indicated time periods. (B) HUVEC on Transwell inserts were incubated for 6 h with
AGE-BSA at various doses or BSA. After incubation, FITC-labeled dextran was added
to the upper compartment. After 1 h of additional incubation at 37 C, the medium
in the lower compartment was collected for ﬂuorometric analysis. AGE-BSA
increased transendothelial diffusion of FITC-labeled dextran in time- and dose-
dependent manners. Unmodiﬁed BSA had no effect on monolayer permeability.
Data are expressed as means ± S.D. (n = 3). *P < 0.05 vs. control for each time period.
#P < 0.05, compared with the group treated with AGE-BSA (–) for 1 h (A). *P < 0.05
vs. control (B).
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ring, but lacked with stress ﬁbers, the cells treated with AGE-BSA
showed prominent actin stress ﬁber and cell contraction (Fig. 2A-
b). We also examined the protein level of VE-cadherin in HUVECs
by Western blotting, but treatment with AGE-BSA for the indicated
time periods did not modify the level of VE-cadherin (Fig. 2B).
3.3. AGE-BSA activates Rho and RhoA forms a complex with RAGE on
HUVECs
To investigate whether these actin rearrangements induced by
AGE-BSA are involved in the activation of Rho–Rho kinase, we
measured Rho activation in HUVECs by pull-down assay using
GST-Rhotekin-Rho-binding domain (GST-RBD). AGE-BSA stimula-
tion increased the amount of activated Rho in HUVECs in a time-
dependent manner (Fig. 3A-a). BSA stimulation for the indicatedtime periods did not modify the amount of activated Rho
(Fig. 3A-b). These results suggest that AGE-BSA induces Rho activa-
tion in HUVECs. To investigate whether Rho is bound to RAGE, we
carried out immunoprecipitation experiments using RhoA and
RAGE antibodies. As shown in Fig. 3B, RhoA formed a complex with
RAGE on HUVECs with or without AGE-BSA stimulation.
3.4. Rho/Rho kinase inhibitor and anti-RAGE antibody inhibits AGE-
BSA-induced cell contraction with actin reorganization and
transendothelial hyperpermeability
To investigate whether these morphological changes induced
by AGE-BSA are due to activation of Rho/Rho kinase, we pretreated
the cells with the Rho kinase inhibitor Y27632 (1 h, 10 lM) and
then stimulated the cells with AGE-BSA. As shown in Fig. 4A,
Y27632 completely blocked the AGE-BSA-induced gap formation
with actin reorganization. To investigate whether these changes
induced by AGE-BSA are mediated through AGE–RAGE interaction,
we pretreated cells with anti-RAGE antibody for 1 h and then stim-
ulated the cells with AGE-BSA. Anti-RAGE antibody blocked AGE-
BSA induced gap formation with actin reorganization. Y27632 or
anti-RAGE antibody also blocked the AGE-BSA induced increase
in endothelial cell permeability. These ﬁndings suggest that activa-
tion of RAGE/Rho is involved in AGE-BSA induced hyperpermeabil-
ity through gap formation and actin reorganization.4. Discussion
Previous studies proposed various mechanisms for the in-
creased microvascular permeability in diabetic mellitus. Endothe-
lial structural changes, weak or loss of adherence junction, cell
contraction, and focal adhesion redistribution are considered in-
volved in hyperpermeability induced by various insults such as
inﬂammatory stimuli [5]. However, apart from these endothelial
structural changes, little is known about the intracellular signals
that propagate these endothelial structural changes and lead to
hyperpermeability. Our study focused on the effect of AGEs on vas-
cular hyperpermeability. AGEs are thought to modulate various
cell functions and play a role in vasculopathies and found the fol-
lowing a sequence of results; RhoA and RAGE spontaneously
formed a complex, AGE-BSA induced Rho activation, intercellular
gap formation, reorganization of actin stress ﬁber and cell contrac-
tion, AGE-BSA induced transendothelial diffusion of FITC-labeled
dextran implying its hyperpermeability. However, our results
showed no changes in VE-cadherin.
It is well known that activation of RAGEs by AGEs transduces
multiple intracellular signal transduction pathways, including
p21ras, MAP kinases, PI3 kinase, NAD(P)H oxidase, and results in
activation of nuclear factor-kappaB (NF-jB) [10]. Another study
also reported that AGEs induced hyperpermeability through actin
rearrangement via ERK and p38 MAPK pathways [4]. However
the relationship with the receptor of AGE and these signaling path-
ways was unclear. On the other hand, little is known about AGEs
and small G protein. Although it was reported that activation of
RAGEs by AGEs induced neurite outgrowth through the cdc42/
Rac pathway [12], the relation between actin polymerization in-
duced by AGEs and Rho signaling is not clear. In this study, we
investigated the role of the Rho signaling pathway in AGE-medi-
ated microvascular hyperpermeability. Rho is a major small GTP-
binding protein and acts a molecular switch that controls a large
variety of signal transduction pathways, many of which regulate
actin cytoskeleton remodeling in various types of cells. Rho relays
extracellular signals to a large number of downstream effectors.
Therefore, Rho is a very important signaling element that cooper-
ates with other small GTP-proteins to regulate various cell
Fig. 2. AGE-BSA induced intercellular gap formation with reorganization of actin cytoskeleton, but no changes in total cellular level of VE cadherin. (A) HUVECs grown on
ﬁbronectin-coated glass-bottom dishes were treated with 50 lg/ml AGE-BSA or BSA. After 6 h, cells were ﬁxed and processed for immunoﬂuorescence analysis of VE-
cadherin (a) and actin (b). HUVEC treated with AGE-BSA showed gap formation and reorganization of the actin cytoskeleton. Untreated control cells or HUVEC treated with
BSA showed no gap formation or stress ﬁber. (B) HUVECs were treated for the indicated time periods with 50 lg/ml AGE-BSA. After washing, cells were extracted with lysis
buffer. Immunoprecipitated VE-cadherin and actin were detected using speciﬁc antibodies. Treatment with AGE-BSA for the indicated time periods did not modify the level of
VE-cadherin protein. Representative results of ﬁve experiments performed with similar results.
Fig. 3. AGE-BSA activated Rho and RhoA forms a complex with RAGE on HUVECs. (A) HUVECs were treated with 50 lg/ml AGE-BSA (a) or BSA (b) as indicated time. After
washing, cells were extracted with lysis buffer. Cell lysates were incubated with GST-RBD beads and RBD-bound Rho were eluted and immunoprecipitated with polyclonal
anti-Rho antibody. AGE-BSA increased Rho-GTP level. (B) HUVECs were treated with or without 50 lg/ml AGE-BSA for 10 min. Lysates were immunoprecipitated with anti-
RAGE monoclonal antibody (a), or anti-RhoA monoclonal antibody (b). Immunoprecipitates were subjected to Western blot analysis using anti-RAGE and anti-Rho
monoclonal antibodies to conﬁrm adequate immunoprecipitation. Representative results of ﬁve experiments performed with similar results.
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Fig. 4. Rho/Rho kinase inhibitor and anti-RAGE antibody blocked AGE-BSA-induced gap formation with actin reorganization and transendothelial hyperpermeability. (A)
HUVECs grown on ﬁbronectin-coated glass-bottom dishes were pretreated with Y27632 (10 lM) then exposed to 50 lg/ml AGE-BSA for 6 h. After incubation, cells were ﬁxed
and processed for immunoﬂuorescence analysis of VE-cadherin and actin. Rho kinase inhibitor decreased gap formation and actin reorganization induced by AGE-BSA. (B)
HUVEC on Transwell inserts were pretreated with Y27632 (10 lM) or anti-RAGE antibody (50 lg/ml), then exposed to 50 lg/ml AGE-BSA for 6 h. After incubation, FITC-
labeled dextran was added and transendothelial diffusion of dextran was calculated. Rho kinase inhibitor and anti-RAGE antibody decreased permeability induced by AGE-
BSA. Data are expressed as means ± S.D. (n = 3). *P < 0.05, compared with the group treated with 50 lg/ml AGE-BSA alone.
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endothelial cells, leading to increased hyperpermeability through
actin polymerization.
RAGE is a member of the immunoglobulin superfamily of recep-
tors [14]. Receptor for IL-1b is also one of the immunoglobulin
superfamily of receptors and the Rho family is a component of
the IL-1 receptor complex [15]. In our study, RAGE and RhoA also
formed a complex with or without stimulation with AGE. Because
RhoA and RAGE spontaneously form a complex, it is likely that AGE
directly activates RhoA. However, further studies including animal
experiments are necessary to clarify the mechanism of RhoA acti-
vation by AGE-BSA.
In summary, our results demonstrated that AGE-BSA induces
reorganization of the actin cytoskeleton through RAGE/Rho activa-
tion, leading to endothelial cell hyperpermeability.
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